OakChart

Addus HomeCare Corp

ADUSHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 11 • 9:05 AM ET

126.23-0.06 (-0.05%)
2026-11-11 15:25 CET
Market cap
2,353.20 USD m
Revenue, TTM
1,501.84 USD m
Net income, TTM
111.05 USD m
Free cash flow, TTM
144.21 USD m
EPS diluted, TTM
6.00
P/E
21.04
Compare

Price

ADUS against its 20, 50 and 200-day averages
2050200miss
90.00100.00110.00120.00130.00405K810KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ADUSclose 126.2320-day 122.4450-day 118.21200-day 107.02126.23

4.1% under 131.59 on 5 Nov 2026. Last 15 sessions, 11.2% high to low

Profile

ADUS
52-week range, 88% of the way up
87.95131.59

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded 1979 and is headquartered in Frisco, TX.

IndexRUT
Employees50659
IPOOct 28, 2009
Beta0.74
ATR, 14d3.73
Rel volume0.23
Short float5.50%
Insider own2.89%
Inst own106.04%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.35B
Enterprise Value2.32B
Income111.05M
Sales1.50B
Book/sh63.32
Cash/sh5.29
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees50659
IPOOct 28, 2009

Ratios

P/E21.04
Forward P/E16.47
PEG1.75
P/S1.57
P/B1.99
P/C23.88
P/FCF16.31
EV/EBITDA12.64
EV/Sales1.55
Quick Ratio1.64
Current Ratio1.64
Debt/Eq0.06
LT Debt/Eq0.05
Option/ShortYes / Yes

Earnings

EPS (ttm)6.00
EPS next Y7.66
EPS next Q1.90
EPS this Y13.66%
EPS next Y8.25%
EPS next 5Y9.43%
EPS past 3/5Y22.39% 20.22%
Sales past 3/5Y14.36% 13.22%
EPS Y/Y TTM27.72%
Sales Y/Y TTM11.53%
EPS Q/Q23.91%
Sales Q/Q7.02%
EarningsNov 03 AMC
EPS/Sales Surpr.2.19% -0.25%

Ownership

Insider Own2.89%
Insider Trans-19.74%
Inst Own106.04%
Inst Trans1.91%
ROA7.73%
ROE9.96%
ROIC9.00%
Gross Margin31.23%
Oper. Margin11.13%
Profit Margin7.39%
SMA203.10%
SMA506.79%
SMA20017.96%
Trades-

Technical

Shs Outstand18.63M
Shs Float18.09M
Short Float5.50%
Short Ratio4.53
Short Interest1.00M
52W High131.59 -4.07%
52W Low87.95 43.53%
Volatility4.78% 2.83%
ATR (14)3.73
RSI (14)62.99
Beta0.74
Rel Volume0.23
Avg Volume219.87K
Volume2,490

Performance

Perf Week-1.33%
Perf Month10.22%
Perf Quarter7.35%
Perf Half Y33.57%
Perf YTD17.55%
Perf Year10.24%
Perf 3Y53.27%
Perf 5Y20.02%
Perf 10Y283.10%
Recom1.64
Target Price140.92
Prev Close126.29
Price126.23
Change %-0.05%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 14, 2026DowngradeBBofA SecuritiesBuy → Neutral$125-1.0%
Jan 07, 2026InitiatedTTruistBuy$135+6.9%
Nov 13, 2025InitiatedBBMO Capital MarketsMarket Perform$120-4.9%
Sep 02, 2025InitiatedUUBSBuy$145+14.9%
Dec 16, 2024InitiatedJJMP SecuritiesMkt Outperform$150+18.8%
Oct 11, 2024InitiatedKKeyBanc Capital MarketsOverweight$150+18.8%
Jun 28, 2024InitiatedMMacquarieOutperform$136+7.7%
Apr 23, 2024DowngradeBBarclaysEqual Weight → Underweight$83-34.2%
Mar 06, 2024InitiatedBBarclaysEqual Weight$88-30.3%
Feb 05, 2024ResumedWWilliam BlairOutperform

Peers

Mkt cap
TickerCompanyMkt cap
AVAHAveanna Healthcare Holdings Inc2.88B
PNTGPennant Group Inc1.28B
CHEChemed Corp7.09B
INNVInnovAge Holding Corp1.27B
BTSGBrightSpring Health Services Inc14.63B
NHCNational Healthcare Corp3.27B
ENSGEnsign Group Inc10.80B
OPCHOption Care Health Inc4.72B
PACSPACS Group Inc7.82B
AMNAMN Healthcare Services Inc1.50B

Insider trading

latest 14 of 56
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ALLISON R DIRKChairman and CEONov 09 '26Option Exercise37.2598,9583,686,186282,108Nov 10 04:31 PM
ALLISON R DIRKChairman and CEONov 09 '26Sale123.2798,95812,198,991183,150Nov 10 04:31 PM
WATTENBARGER MICHAEL D.EVP, Chief Information OfficerNov 06 '26Option Exercise87.805,000439,00014,444Nov 10 04:31 PM
WATTENBARGER MICHAEL D.EVP, Chief Information OfficerNov 06 '26Sale124.677,141890,2787,303Nov 10 04:31 PM
RAINES MONICAEVP, CCO and Quality OfficerNov 06 '26Option Exercise34.052,06270,21115,639Nov 10 04:31 PM
RAINES MONICAEVP, CCO and Quality OfficerNov 06 '26Sale124.742,062257,21413,577Nov 10 04:31 PM
TUCKER DAVID W.EVP, Chief Strategy OfficerNov 06 '26Option Exercise87.8012,5001,097,50022,923Nov 10 04:30 PM
TUCKER DAVID W.EVP, Chief Strategy OfficerNov 06 '26Sale124.7514,8501,852,5738,073Nov 10 04:30 PM
POFF BRIANEVP, Chief Financial OfficerNov 06 '26Sale124.726,644828,64257,048Nov 10 04:30 PM
BLESSING CLIFF DONALDEVP, Chief Development OfficerNov 06 '26Sale124.182,000248,36010,183Nov 10 04:30 PM
DARBY ANDERSONOfficerNov 10 '26Proposed Sale122.716,740827,084Nov 10 04:12 PM
CLIFF BLESSINGOfficerNov 10 '26Proposed Sale123.913,499433,555Nov 10 04:09 PM
DIRK ALLISONOfficerNov 09 '26Proposed Sale123.2798,95812,198,840Nov 09 05:21 PM
DAVID TUCKEROfficerNov 06 '26Proposed Sale124.7514,8501,852,566Nov 06 05:23 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B

News

latest 14 of 206
  • Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference (Business Wire)
  • Addus HomeCare Edges Past Estimates As Margins Expand, But Softer Personal Care Volumes And A Dilutive 2027 Margin Outlook Temper The AccentCare Story (Earnings Whispers)
  • Addus HomeCare falls on revenue miss despite earnings beat (Investing.com)
  • Addus HomeCare: Q3 Earnings Snapshot (Associated Press)
  • Addus HomeCare Announces Third Quarter 2026 Financial Results (Business Wire)
  • Loading…
  • Addus HomeCare Must Prove Its Personal Care Census Turn Is Durable As Shares Press Highs (Earnings Whispers)
  • Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call (Business Wire)
  • Should You Trim Or Add To Your Hims & Hers Position Now? (Trefis)
  • Is Hims & Hers Stock Ready For A Longer Cash Burn? (Trefis)
  • Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare (Business Wire)
  • Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference (Business Wire)
  • Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest (Trefis)
  • Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash (Trefis)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-031.8301.7911.540387.74388.7214
2026Q22026-08-031.7301.6981.495377.41376.2414
2026Q12026-05-041.6201.5451.356363.5366.4114
2025Q42026-02-231.7701.7231.608372.08372.8814
2025Q32025-11-031.5601.5341.242362.3354.5311
2025Q22025-08-041.4901.4691.203349.44346.5111
2025Q12025-05-051.4201.3331.159337.7339.9210
2024Q42025-02-241.3801.3611.067293.7291.4611
2024Q32024-11-041.3001.2841.105289.79289.4610
2024Q22024-08-051.3501.2141.096286.92284.99
2024Q12024-05-061.2101.1110.967280.75279.498
2023Q42024-02-261.3201.1721.201276.35274.478
2023Q32023-10-301.1501.0830.946270.72267.157
2023Q22023-07-311.0701.0100.912259.98256.317
2023Q12023-05-010.9700.8750.778251.6250.058
2022Q42023-02-271.1100.9530.908247.05246.149

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.6001.5501.177425.72424.2
2018FY1.9601.8701.327518.12517.67
2019FY2.5002.3611.771648.79641.26
2020FY3.0802.9812.077764.78766.33
2021FY3.6303.4182.809864.5865.59
2022FY3.7303.5322.844950.36950.22
2023FY4.5804.3573.8331,0571,057
2024FY5.2605.2284.2351,0831,149
2025FY6.2306.1945.2201,4181,422
2026FY-7.081--1,524
2027FY-7.665--1,655
2028FY-8.164--1,755

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-051310394.7390.4399
2026Q4S2026-11-041310394.61390.4399
2026Q4S2026-11-031300393.77387.2397.4
2026Q4S2026-10-181300393.77387.2397.4
2026Q4S2026-10-091340393.77387.2397.4
2026Q4S2026-09-141340393.77387.2397.4
2026Q4S2026-09-011340393.99387.2397.4
2026Q4S2026-08-041340393.99387.2397.4
2026Q4S2026-07-191300391.94381.69397.75
2026Q4S2026-07-131311391.94381.69397.75
2026Q4S2026-05-121311391.9381.69397.75
2026Q4S2026-05-101321391.93381.69397.75
2026Q4S2026-05-061324391.93381.69397.75
2026Q4S2026-05-051324392.05381.69397.75

Estimate history

EPS, annual1.1771.3271.7712.0772.8092.8443.8334.2355.2155.9984
Period201720182019202020212022202320242025TTM
EPS, quarterly1.1051.0671.1591.2031.2421.6081.3561.4951.54
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual425.994516.647648.791764.775864.499951.121058.6511154.5991422.531501.84
Period201720182019202020212022202320242025TTM
Sales, quarterly289.787297.144337.708349.443362.301373.078363.611377.417387.733
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual11.63213.12615.61715.82615.9416.12816.22718.14818.51818.633
Period201720182019202020212022202320242025MRQ
Shares, quarterly18.13318.14818.39918.40718.48318.51818.66518.67418.633
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,501.841,422.531,154.601,058.65951.12864.50764.77648.79516.65
Cost of Goods Sold Incl. D&A1,032.84977.07793.11730.10660.74590.75549.11480.13388.49
Gross Profit469.00445.46361.49328.55290.38273.75215.67168.66128.16
Selling, General and Administrative Excl. Other301.89296.45245.76231.68210.97186.32169.08129.21100.80
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income167.11149.01115.7396.8779.4187.4446.5939.4527.36
Interest Expense7.8713.617.7311.118.915.813.193.105.02
Unusual Expense-10.4016.775.9110.6721.502.084.704.50
Net Income Before Taxes149.50127.4499.3581.3360.1760.4041.9433.1720.40
Income Taxes38.4531.5425.7518.8114.1515.278.817.364.10
Consolidated Net Income111.0595.9173.6062.5246.0245.1333.1325.8116.31
Net Income From Continuing Operations111.0595.9173.6062.5246.0245.1333.1325.8116.31
Net Income111.0595.9173.6062.5246.0245.1333.1325.2416.43
EPS (Recurring)5.985.614.914.093.313.752.172.001.58
EPS (Basic, Before Extraordinaries)6.065.314.333.912.902.872.121.831.36
EPS (Diluted)6.005.214.233.832.842.812.081.771.33
EBITDA183.55165.43129.26111.0093.47101.9358.6450.0336.01
Non-Operating Income (Expense)2.262.448.121.480.340.270.621.522.55
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense13.3912.978.828.158.396.894.384.213.25
Price To Earnings Ratio21.0521.0528.7026.2036.1733.2656.3655.6947.93
Price To Sales Ratio1.371.391.891.431.691.742.442.141.63
Gross Margin31.2331.3131.3131.0330.5331.6728.2026.0024.81
Operating Margin11.1310.4810.029.158.3510.116.096.085.30
Net Margin7.396.746.375.914.845.224.333.893.18
Shares Outstanding18.6318.5218.1516.2316.1315.9415.8315.6213.13
Market Capitalization2,353.202,353.202,272.981,505.531,602.821,489.371,851.041,274.36889.09

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue387.73377.42363.61373.08362.30349.44337.71297.14
Cost of Goods Sold Incl. D&A267.47259.98251.77253.62249.99239.48233.97198.88
Gross Profit120.26117.44111.84119.46112.31109.96103.7398.27
Selling, General and Administrative Excl. Other80.4478.4976.1766.7879.3777.0873.2258.31
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income39.8238.9435.6752.6832.9432.8930.5139.95
Interest Expense1.261.722.152.733.343.524.022.29
Unusual Expense-0.001.6010.400.000.000.0016.77
Net Income Before Taxes39.1437.7832.4340.1530.3529.9527.0026.21
Income Taxes10.5510.187.3610.377.517.895.776.69
Consolidated Net Income28.5927.6125.0729.7822.8522.0521.2319.53
Net Income From Continuing Operations28.5927.6125.0729.7822.8522.0521.2319.53
Net Income28.5927.6125.0729.7822.8522.0521.2319.53
EPS (Recurring)1.541.491.422.001.241.201.161.71
EPS (Basic, Before Extraordinaries)1.561.511.381.611.261.221.181.08
EPS (Diluted)1.541.491.361.611.241.201.161.07
EBITDA43.9643.0739.7056.8237.3436.8034.4643.17
Non-Operating Income (Expense)0.590.570.510.600.760.580.505.31
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.383.473.953.593.394.422.502.26
Price To Earnings Ratio21.0518.5717.9722.9926.0226.0223.3528.70
Price To Sales Ratio1.371.261.201.401.611.661.491.99
Gross Margin31.0231.1230.7632.0231.0031.4730.7233.07
Operating Margin10.2710.329.8114.129.099.419.0413.45
Net Margin7.377.316.897.986.316.316.296.57
Shares Outstanding18.6318.6718.6618.5218.4818.4118.4018.15
Market Capitalization2,353.201,875.251,745.971,984.922,171.872,119.391,797.122,272.98

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments81.6298.9164.7979.96168.90145.08111.7170.4153.75
Short Term Receivables162.69135.26116.08126.17146.07135.04153.24100.5796.42
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets25.1826.2119.1416.689.387.584.445.045.49
Total Current Assets269.49260.38200.00222.81324.34287.70269.39176.01155.67
Net Property, Plant & Equipment68.7172.0569.4460.1654.5357.7433.2710.667.49
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets1,099.111,080.20754.98655.02568.71540.62332.45159.23106.94
Deferred Tax Assets43.6351.79--0.0038.7724.0714.7810.01
Other Assets0.000.000.000.000.000.000.000.000.00
Total Assets1,480.941,464.421,024.43937.99947.59924.82659.17360.68280.10
Short Term Debt Incl. Current Port. of LT Debt13.1412.8011.3410.809.7710.257.960.063.10
Accounts Payable16.8327.1826.1822.0919.3623.7019.6412.247.38
Other Current Liabilities119.51115.89107.5998.2588.56109.9459.9249.2044.60
Total Current Liabilities149.49155.87145.12131.15117.69143.9087.5361.5055.08
Long Term Debt158.22260.33163.84167.25253.77229.4273.4717.2239.86
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities87.7077.61---32.2422.4212.588.41
Other Liabilities0.230.128.776.061.780.590.160.880.45
Total Liabilities395.64493.93317.73304.45373.24406.15183.5892.19103.79
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,085.30970.49706.69633.54574.34518.68475.59268.49176.31
Total Shareholders Equity1,085.30970.49706.69633.54574.34518.68475.59268.49176.31
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,085.30970.49706.69633.54574.34518.68475.59268.49176.31
Total Liabilities & Stockholders Equity1,480.941,464.421,024.43937.99947.59924.82659.17360.68280.10
Book Value Per Share58.6153.4843.5539.2836.0332.7730.4520.4515.16
Tangible Book Value Per Share-0.75-6.05-2.98-1.330.35-1.399.178.325.96
Full-Time Employees50,65949,70334,84633,18231,91535,13933,23833,15333,153
Price to Book Ratio1.992.402.202.602.603.573.193.232.35
Return on Assets6.515.916.374.884.824.185.035.095.20
Return on Equity9.338.789.337.628.266.666.877.338.10
Return on Invested Capital7.715.987.185.755.454.434.605.756.33
Quick Ratio1.801.671.381.702.762.003.082.862.83
Current Ratio1.801.671.381.702.762.003.082.862.83

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income111.0595.9173.6062.5246.0245.1333.1325.2416.43
Depreciation16.4416.4113.5314.1314.0614.4912.0510.578.64
Other Funds (Non Cash)19.7619.3014.6111.9013.3411.208.926.834.18
Funds from Operations164.75149.49114.9391.3677.3378.1049.4541.5728.88
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-12.72-37.981.5120.8927.78-38.6159.96-29.554.33
Cash from Operating Activities152.03111.51116.43112.25105.1139.49109.4112.0233.20
Capital Expenditures-7.82-7.72-6.05-9.45-8.30-4.64-6.83-4.62-5.35
Net Assets From Acquisitions-19.58-31.58-353.95-109.80-98.29-37.37-207.66-184.08-62.44
Sale of Fixed Assets and Businesses-2.783.865.390.010.000.000.260.000.00
Purchase or Sale of Investments2.942.940.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments2.942.940.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-27.25-32.50-354.61-119.24-106.59-42.02-214.24-188.70-67.79
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.792.48179.030.322.551.113.95176.1077.61
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.792.48179.030.322.551.113.95176.1077.61
Proceedsfrom Stock Options0.000.00175.600.000.000.000.00172.9476.62
Issuance or Reduction of Debt, Net-130.01-98.7893.26-8.50-90.0025.24134.2441.89-26.37
Change in Long Term Debt-130.01-98.7893.26-8.50-90.0025.24134.2441.89-26.37
Issuance of Long Term Debt-0.0111.22229.61110.0047.0043.37135.0042.6979.50
Reduction of Long Term Debt-130.00-110.00-136.35-118.50-137.00-18.13-0.76-0.80-105.87
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-128.22-96.30272.30-8.18-87.4526.34138.19217.9951.24
Net Change in Cash-3.44-17.2934.12-15.17-88.9323.8233.3641.3116.65
Free Cash Flow144.21103.79110.38102.7996.8134.84102.587.4027.85
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow14.2419.0319.7414.7316.6343.1118.21187.2430.18
Deferred Taxes & Investment Tax Credit-17.8713.192.823.917.28-4.65-1.06-0.38

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments98.4899.57103.0681.62101.9291.18
Short Term Receivables162.37146.84148.56162.69137.11144.10
Inventories0.000.000.000.000.000.00
Other Current Assets20.3737.7421.2525.1821.6327.77
Total Current Assets281.23284.15272.88269.49260.66263.05
Net Property, Plant & Equipment63.4464.8965.6668.7169.3270.41
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1,105.521,107.451,097.171,099.111,092.951,075.48
Deferred Tax Assets---43.63--
Other Assets0.000.000.000.000.000.00
Total Assets1,450.181,456.491,435.701,480.941,422.941,408.93
Short Term Debt Incl. Current Port. of LT Debt12.7613.0613.1413.1413.0312.97
Accounts Payable20.1318.0414.0416.8316.6815.69
Other Current Liabilities138.56137.05122.30119.51127.09122.73
Total Current Liabilities171.44168.15149.47149.49156.80151.38
Long Term Debt54.5795.76125.61158.22189.45209.28
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities44.3544.3744.2087.7026.4826.29
Other Liabilities0.050.050.260.230.240.12
Total Liabilities270.42308.33319.54395.64372.96387.08
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,179.761,148.161,116.161,085.301,049.971,021.85
Total Shareholders Equity1,179.761,148.161,116.161,085.301,049.971,021.85
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,179.761,148.161,116.161,085.301,049.971,021.85
Total Liabilities & Stockholders Equity1,450.181,456.491,435.701,480.941,422.941,408.93
Book Value Per Share63.3261.4859.8058.6156.8155.51
Tangible Book Value Per Share3.982.181.02-0.75-2.33-2.91
Full-Time Employees---50,659--
Price to Book Ratio1.991.681.601.892.132.13
Return on Assets7.737.357.026.516.656.57
Return on Equity9.969.719.459.338.588.54
Return on Invested Capital2.322.222.022.391.841.79
Quick Ratio1.641.691.831.801.661.74
Current Ratio1.641.691.831.801.661.74

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income28.5927.6125.0729.7822.8522.05
Depreciation4.144.124.034.154.413.91
Other Funds (Non Cash)3.585.125.675.395.015.06
Funds from Operations36.3037.0134.9056.5332.4631.32
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital4.603.0017.45-37.7718.83-8.82
Cash from Operating Activities40.9140.0152.3518.7651.2922.51
Capital Expenditures-2.11-1.34-1.71-2.66-1.92-1.25
Net Assets From Acquisitions0.00-12.180.00-7.40-20.830.00
Sale of Fixed Assets and Businesses0.110.020.02-2.93-0.012.96
Purchase or Sale of Investments0.000.000.002.940.00-0.01
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.002.940.00-0.01
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-2.00-13.51-1.69-10.06-22.761.70
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.791.000.98-0.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.791.000.98-0.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-40.00-30.00-30.00-30.01-18.77-30.00
Change in Long Term Debt-40.00-30.00-30.00-30.01-18.77-30.00
Issuance of Long Term Debt0.000.000.00-0.0111.230.00
Reduction of Long Term Debt-40.00-30.00-30.00-30.00-30.00-30.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-40.00-30.00-29.21-29.01-17.79-29.98
Net Change in Cash-1.09-3.5021.45-20.3010.74-5.78
Free Cash Flow38.8038.6750.6416.1049.3721.25
Price to Free Cash Flow14.2411.9912.6019.1622.5122.55

Revenue breakdown

United States2024: 1.15B 2025: 1.42B
Home Health2024: 69.83M 2025: 70.77M
Hospice2024: 228.19M 2025: 262.54M
Personal Care2024: 856.58M 2025: 1.09B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.50%1.0M18.1M207.01K
2026-10-154.27%0.8M18.1M212.98K
2026-09-305.09%0.9M18.1M223.44K
2026-09-154.85%0.9M18.1M233.10K
2026-08-314.94%0.9M18.1M233.92K
2026-08-145.59%1.0M18.1M237.39K
2026-07-316.65%1.2M18.1M257.50K
2026-07-156.91%1.3M18.1M257.33K
2026-06-305.83%1.1M18.1M256.05K
2026-06-155.13%0.9M18.1M244.40K
2026-05-295.30%1.0M18.1M247.44K
2026-05-155.04%0.9M18.1M263.86K
2026-04-304.74%0.9M18.1M247.83K
2026-04-154.94%0.9M18.1M246.82K
2026-03-315.07%0.9M18.1M234.32K
2026-03-135.57%1.0M18.1M218.00K
2026-02-275.18%0.9M18.0M210.84K
2026-02-136.38%1.1M18.0M193.84K
2026-01-305.17%0.9M18.0M191.16K
2026-01-154.30%0.8M18.0M176.78K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call60.000.000.000.00-0.000.00---
call65.000.000.000.00-0.000.00---
call70.000.000.000.00-0.000.00---
call75.000.000.000.00-0.000.00---
call80.000.000.000.00-0.000.00---
call85.000.000.000.00-0.000.00---
call90.000.000.000.00-0.000.00---
call95.000.000.000.00-0.000.00---
call1000.000.000.00-0.000.00---
call1050.000.000.00-0.000.00---
call1100.000.000.00-0.000.00---
call1150.000.005.35-1.000.00---
call1200.000.009.40-2.000.00---
call1250.000.005.60-3.000.00---
call1300.000.001.05-2260.00---
call1350.000.000.00-0.000.00---
call1400.000.000.00-0.000.00---
call1450.000.000.00-0.000.00---
call1500.000.000.00-0.000.00---
call1550.000.000.00-0.000.00---
call1600.000.000.00-0.000.00---
call1650.000.000.00-0.000.00---
call1700.000.000.00-0.000.00---
put60.000.000.000.00-0.000.00---
put65.000.000.000.00-0.000.00---
put70.000.000.000.00-0.000.00---
put75.000.000.000.00-0.000.00---
put80.000.000.000.00-0.000.00---
put85.000.000.000.00-0.000.00---
put90.000.000.000.00-0.000.00---
put95.000.000.000.00-0.000.00---
put1000.000.000.00-0.000.00---
put1050.000.000.00-0.000.00---
put1100.000.000.00-0.000.00---
put1150.000.001.80-1.000.00---
put1200.000.000.00-0.000.00---
put1250.000.004.71-1.000.00---
put1300.000.0013.50-2.000.00---
put1350.000.000.00-0.000.00---
put1400.000.000.00-0.000.00---
put1450.000.000.00-0.000.00---
put1500.000.000.00-0.000.00---
put1550.000.000.00-0.000.00---
put1600.000.000.00-0.000.00---
put1650.000.000.00-0.000.00---
put1700.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-09-148-KCurrent report2026-09-12SEC
2026-08-173Initial statement of beneficial ownership of securities2026-08-07SEC
2026-08-138-KCurrent report2026-08-07SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-108-KCurrent report2026-06-10SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110016.28M6
2026-100000
2026-090000
2026-080000
2026-070000
2026-060027.01K1
2026-050046.50K2
2026-040016.66K1
2026-030022.88K1
2026-02002.97M27
2026-010000
2025-120036.00K2
2025-11002.18M1

Institutional holders

Manager% owned
BlackRock, Inc.18.35%
Capital Research Global Investors7.45%
DIMENSIONAL FUND ADVISORS LP4.90%
VANGUARD CAPITAL MANAGEMENT LLC4.23%
STATE STREET CORP4.17%
SILVERCREST ASSET MANAGEMENT GROUP LLC3.70%
WASATCH ADVISORS LP3.36%
GEODE CAPITAL MANAGEMENT, LLC3.27%
FMR LLC3.09%
AMERICAN CENTURY COMPANIES INC3.03%

Funds

Fund% owned
SMALLCAP World Fund Inc7.25%
iShares Core S&P Small-Cap ETF5.90%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
iShares Russell 2000 ETF2.60%
Small Cap Value Fund1.63%
Wasatch Small Cap Growth Fund1.37%
VANGUARD EXTENDED MARKET INDEX FUND1.12%
Fidelity Small Cap Index Fund1.09%
Bridge Builder Small/Mid Cap Value Fund1.09%
BlackRock Advantage Small Cap Core Fund0.93%

OakChart. ADUS. Cached 15 minutes.